Immunologic therapy for relapsing-remitting multiple sclerosis.
MacLean, H J
Immunologic therapy for relapsing-remitting multiple sclerosis. [electronic resource] - Current neurology and neuroscience reports May 2001 - 277-85 p. digital
Publication Type: Comparative Study; Journal Article; Review
1528-4042
10.1007/s11910-001-0031-9 doi
Adjuvants, Immunologic--therapeutic use
Adrenal Cortex Hormones--therapeutic use
Anti-Inflammatory Agents--therapeutic use
Autoimmune Diseases--drug therapy
Azathioprine--therapeutic use
Clinical Trials as Topic
Cyclophosphamide--therapeutic use
Disease Progression
Drug Administration Schedule
Forecasting
Glatiramer Acetate
Humans
Immunoglobulins, Intravenous--therapeutic use
Immunosuppressive Agents--therapeutic use
Immunotherapy
Interferon beta-1a
Interferon beta-1b
Interferon-beta--therapeutic use
Longitudinal Studies
Methotrexate--therapeutic use
Mitoxantrone--therapeutic use
Multiple Sclerosis--drug therapy
Peptides--therapeutic use
Plasma Exchange
Plasmapheresis
Steroids
Treatment Outcome
Immunologic therapy for relapsing-remitting multiple sclerosis. [electronic resource] - Current neurology and neuroscience reports May 2001 - 277-85 p. digital
Publication Type: Comparative Study; Journal Article; Review
1528-4042
10.1007/s11910-001-0031-9 doi
Adjuvants, Immunologic--therapeutic use
Adrenal Cortex Hormones--therapeutic use
Anti-Inflammatory Agents--therapeutic use
Autoimmune Diseases--drug therapy
Azathioprine--therapeutic use
Clinical Trials as Topic
Cyclophosphamide--therapeutic use
Disease Progression
Drug Administration Schedule
Forecasting
Glatiramer Acetate
Humans
Immunoglobulins, Intravenous--therapeutic use
Immunosuppressive Agents--therapeutic use
Immunotherapy
Interferon beta-1a
Interferon beta-1b
Interferon-beta--therapeutic use
Longitudinal Studies
Methotrexate--therapeutic use
Mitoxantrone--therapeutic use
Multiple Sclerosis--drug therapy
Peptides--therapeutic use
Plasma Exchange
Plasmapheresis
Steroids
Treatment Outcome